Evidence map›Paper›PMID 38289221›Full record

ArticleeLife2024

Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function.

Chao Chang, Sara L Banerjee, Sung Soon Park, Xiao Lei Zhang, David Cotnoir-White, Karla J Opperman, Muriel Desbois, Brock Grill, Artur Kania

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Chao ChangInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.ORCID https://orcid.org/0009-0007-3154-996X
Sara L BanerjeeInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.ORCID https://orcid.org/0000-0003-0295-2825
Sung Soon ParkInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
Xiao Lei ZhangInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
David Cotnoir-WhiteInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.
Karla J OppermanCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States.
Muriel DesboisCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States.ORCID https://orcid.org/0000-0002-8070-2525
Brock GrillCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States.
Artur KaniaInstitut de recherches cliniques de Montréal (IRCM), Montréal, Canada.ORCID https://orcid.org/0000-0002-5209-2520
Montreal Clinical Research Institute · CAKeele University · GBUniversity of Washington · US

Funding

Mechanisms of synapse formation and axon termination in C. elegansR01NS072129 · NINDS · UNIVERSITY OF MINNESOTA · PI GRILL, BROCK · 2011 to 2024
$8.0M
CIHR MOP-77556CIHR PJT-153053CIHR PJT-159839CIHR PJT-162225NIH HHS R01 NS072129NINDS NIH HHS R01 NS072129
6 · The paper itself

Abstract

Eph receptor tyrosine kinases participate in a variety of normal and pathogenic processes during development and throughout adulthood. This versatility is likely facilitated by the ability of Eph receptors to signal through diverse cellular signalling pathways: primarily by controlling cytoskeletal dynamics, but also by regulating cellular growth, proliferation, and survival. Despite many proteins linked to these signalling pathways interacting with Eph receptors, the specific mechanisms behind such links and their coordination remain to be elucidated. In a proteomics screen for novel EPHB2 multi-effector proteins, we identified human MYC binding protein 2 (MYCBP2 or PAM or Phr1). MYCBP2 is a large signalling hub involved in diverse processes such as neuronal connectivity, synaptic growth, cell division, neuronal survival, and protein ubiquitination. Our biochemical experiments demonstrate that the formation of a complex containing EPHB2 and MYCBP2 is facilitated by FBXO45, a protein known to select substrates for MYCBP2 ubiquitin ligase activity. Formation of the MYCBP2-EPHB2 complex does not require EPHB2 tyrosine kinase activity and is destabilised by binding of ephrin-B ligands, suggesting that the MYCBP2-EPHB2 association is a prelude to EPHB2 signalling. Paradoxically, the loss of MYCBP2 results in increased ubiquitination of EPHB2 and a decrease of its protein levels suggesting that MYCBP2 stabilises EPHB2. Commensurate with this effect, our cellular experiments reveal that MYCBP2 is essential for efficient EPHB2 signalling responses in cell lines and primary neurons. Finally, our genetic studies in

Indexed as

Adaptor Proteins, Signal TransducingF-Box ProteinsReceptor, EphB2Ubiquitin-Protein LigasesAnimalsCaenorhabditis elegansHumansSignal TransductionUbiquitinUbiquitinationAdaptor Proteins, Signal TransducingEPHB2 protein, humanF-Box ProteinsFBXO45 protein, humanMYCBP2 protein, humanReceptor, EphB2UbiquitinUbiquitin-Protein LigasesC. eleganscell biologychickendevelopmental biologyEph receptorhumanmouseMycbp2neuronproteomicsratsignalling hub

Identifiers

PMID38289221
PMCPMC10945567
OpenAlexW4385066321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.